9/9/2020 8:36:02 AM
NuVasive Announces Limited Availability Of The New Precice Plate
8/4/2020 4:04:26 PM
NuVasive Q2 GAAP Net Loss/Shr $0.98; Non-GAAP Net Loss/Shr $0.40
7/22/2020 9:10:25 AM
NuVasive' Invasive Procedural Solutions Proven To Reduce Operative Time And Improve Patient Outcomes In Spine Surgery
7/20/2020 4:07:42 PM
NuVasive Estimates Q2 Net Sales Of $202 Mln-$205 Mln, Down 30% From Last Year
6/18/2020 8:39:21 AM
NuVasive Launches Reline 3D, Posterior Fixation System For Patients Suffering From Pediatric Spinal Deformities
5/28/2020 12:20:12 AM
NuVasive Announces Pricing Of Offering Of $400 Mln Of 1.00% Convertible Senior Notes Due 2023
5/26/2020 4:09:55 PM
NuVasive Announces Proposed Offering Of $400 Million Of Convertible Senior Notes Due 2023
5/6/2020 4:04:42 PM
NuVasive Q1 GAAP EPS $0.10; Non-GAAP EPS $0.48
5/5/2020 8:34:46 AM
NuVasive Expands Advanced Materials Science Implant Portfolio To Additional Thoracolumbar Procedures
3/10/2020 8:37:46 AM
NUVA: Attrax Putty Ceramic Bone Graft Substitute Supported By Level I Evidence To Show Non-inferior Fusion Performance
2/27/2020 2:26:02 AM
NuVasive Reports Pricing Of Offering Of $450 Mln Of 0.375% Convertible Senior Notes Due 2025
2/26/2020 8:06:47 AM
NuVasive Announces Proposed Offering Of $450 Mln Of Convertible Senior Notes Due 2025